Trends Using AI to Predict HCP Prescribing Behavior
A panel of pharmaceutical executives shares their respective experiences using AI for prescriptive analytics and some of the constraints that impact usability. Leaders reflect on the role of AI in their organizations and identify key barriers to implementation, how they were able to overcome those challenges and opportunities for the improvement of AI and prescriptive analytics in the future. Key discussion points included the importance of obtaining business leader buy-in and trust, the value of using analytics to optimize communication strategies, and methods to speed the generation of insights.
Participates in the roundtable discussion were Greg Nagel, Head of Real-World Analytics and Data, Sumitovant BioPharma Inc; Andrea S. Thomas, Director of Analytics Excellence, GSK US Pharma Commercial Insights; Mike Steward, Chief Digital Officer, and Principal, Analytical Wizards; and Julian Upton (Moderator), European and Online Editor, Pharmaceutical Executive.
Please fill the brief form to download this whitepaper…
For more information, please contact us at